Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference61 articles.
1. Multiple roles for CD4+ T cells in anti-tumor immune responses.;R Kennedy;Immunol Rev,2008
2. The role of CD4+ T cell responses in antitumor immunity.;DM Pardoll;Curr Opin Immunol,1998
3. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.;E Jager;Proc Natl Acad Sci U S A,2000
4. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.;S Gnjatic;Proc Natl Acad Sci U S A,2003
5. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.;ID Davis;Proc Natl Acad Sci U S A,2004
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells;Blood Cancer Discovery;2023-10-17
2. In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms;Journal of Materials Science: Materials in Medicine;2021-05-17
3. Telomerase and CD4 T Cell Immunity in Cancer;Cancers;2020-06-25
4. Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms;Cancer Gene Therapy;2020-05-27
5. Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine;Vaccines;2015-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3